THE ABILITIES OF SPECIFIC KAPPA-OPIOID AGONISTS, U-50,488H AND U-62,066E, TO CAUSE ANTITUSSIVE TOLERANCE WERE LOWER THAN THAT OF MORPHINE

被引:4
作者
KAMEI, J
TANIHARA, H
KASUYA, Y
机构
[1] Department of Pharmacology, School of Pharmacy, Hoshi University, Shinagawa-ku, Tokyo 142, 4-41
关键词
D O I
10.1254/jjp.56.557
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We examined whether the chronic administration of selective kappa-opioid agonists could produce antitussive tolerance, in a comparison with the mu-opioid morphine. A certain degree of tolerance to the antitussive effects of morphine appeared in rats treated chronically with this drug. However, chronic administration of U-50,488H and U-62,066E, highly selective agonists for the kappa-opioid receptor, does not result in the development of tolerance to their respective antitussive effects. These results suggest that the ability of kappa-opioid agonists to cause tolerance to their respective antitussive effects was lower than that of a mu-opioid agonist.
引用
收藏
页码:557 / 561
页数:5
相关论文
共 11 条
[1]  
BENNETT JP, 1976, MOL PHARMACOL, V12, P373
[2]   EFFECTS OF MORPHINE IN RATS TREATED CHRONICALLY WITH U-50,488 H, A KAPPA-OPIOID RECEPTOR AGONIST [J].
BHARGAVA, HN ;
RAMARAO, P ;
GULATI, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 162 (02) :257-264
[3]  
HO BY, 1989, J PHARMACOL EXP THER, V250, P508
[4]  
KAMEI J, 1989, EUR J PHARMACOL, V168, P153
[5]   SUBSENSITIVITY TO THE COUGH-DEPRESSANT EFFECTS OF OPIOID AND NONOPIOID ANTITUSSIVES IN MORPHINE-DEPENDENT RATS - RELATIONSHIP TO CENTRAL SEROTONIN FUNCTION [J].
KAMEI, J ;
MORI, T ;
OGAWA, M ;
KASUYA, Y .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (03) :595-598
[6]   ANTITUSSIVE EFFECTS OF 2 SPECIFIC KAPPA-OPIOID AGONISTS, U-50,488H AND U-62,066E, IN RATS [J].
KAMEI, J ;
TANIHARA, H ;
KASUYA, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 187 (02) :281-286
[7]   U-50488H,A PURE KAPPA RECEPTOR AGONIST WITH SPINAL ANALGESIC LOCI IN THE MOUSE [J].
PIERCEY, MF ;
LAHTI, RA ;
SCHROEDER, LA ;
EINSPAHR, FJ ;
BARSUHN, C .
LIFE SCIENCES, 1982, 31 (12-1) :1197-1200
[8]  
PORRECA F, 1987, J PHARMACOL EXP THER, V240, P890
[9]  
TAKEMORI AE, 1988, J PHARMACOL EXP THER, V246, P255
[10]  
VONVOIGTLANDER PF, 1983, J PHARMACOL EXP THER, V224, P7